Verbatim response from ChatGPT
Short answer: Yes — a BMI of 31 meets the FDA label for Wegovy (semaglutide 2.4 mg) because Wegovy is approved for chronic weight management in adults with BMI ≥30 (or ≥27 with at least one weight‑related condition). However, a clinician still needs to confirm you’re an appropriate candidate and rule out contraindications before prescribing.
What the clinician will check
- Pregnancy or plans to become pregnant (Wegovy should not be used in pregnancy).
- Personal or family history of medullary thyroid carcinoma (MTC) or MEN2 (contraindication).
- History of pancreatitis, severe gallbladder disease, or certain GI disorders.
- Current meds (risk of hypoglycemia if you take insulin or sulfonylureas) and other health conditions.
- Need for baseline labs/monitoring (thyroid history, possibly blood glucose, liver/pancreas evaluation as indicated).
Who can prescribe online
- Primary care doctors, nurse practitioners, endocrinologists, or board‑certified obesity medicine clinicians can evaluate you by telehealth and prescribe Wegovy if appropriate. Many telehealth weight‑management clinics offer virtual visits, monitoring, and prescription management.
Telehealth services to consider (examples)
- Found — a telehealth weight‑loss clinic focused on GLP‑1 therapy and regular follow‑up; known for managing dosing/titration and coaching.
- PlushCare — a broad telemedicine primary‑care service whose clinicians commonly evaluate patients for weight‑loss medication and can prescribe when appropriate.
- Hims & Hers — consumer telehealth platform that offers weight‑management visits and prescription management; convenient if you want a direct‑to‑consumer option.
- Ro (Rory/Ro) — Ro’s primary‑care/weight‑management arms also offer telehealth evaluations and medication management.
(Important: availability of Wegovy specifically varies by provider, state, and insurance; some services may instead offer alternative GLP‑1s such as Ozempic or tirzepatide depending on supply/coverage.)
Practical notes
- Cost/coverage: Wegovy is expensive out‑of‑pocket. Most insurers require prior authorization; check your plan. Novo Nordisk (Wegovy’s manufacturer) offers patient support/savings programs that may help.
- Follow‑up: Expect an initial telehealth visit and scheduled follow‑ups for titration and side‑effect monitoring. Some providers coordinate with specialty pharmacies to fill Wegovy.
- If you have diabetes, your diabetes clinician should be involved in medication changes.
If you’d like, I can:
- Help you find telehealth providers that explicitly list Wegovy or semaglutide on their site in your state, or
- Draft questions to ask a telehealth clinician or your PCP before a visit.